Sisram Medical Ltd
HKEX:1696
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.7163
6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sisram Medical Ltd
Sisram Medical Ltd
Cash & Cash Equivalents
Sisram Medical Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sisram Medical Ltd
HKEX:1696
|
Cash & Cash Equivalents
$70.2m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Nano-X Imaging Ltd
NASDAQ:NNOX
|
Cash & Cash Equivalents
$56.4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
Brainsway Ltd
TASE:BWAY
|
Cash & Cash Equivalents
$46m
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
16%
|
|
|
Inmode Ltd
NASDAQ:INMD
|
Cash & Cash Equivalents
$403.4m
|
CAGR 3-Years
49%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sofwave Medical Ltd
TASE:SOFW
|
Cash & Cash Equivalents
$24.4m
|
CAGR 3-Years
110%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
Epitomee Medical Ltd
TASE:EPIT
|
Cash & Cash Equivalents
$15.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sisram Medical Ltd
Glance View
Sisram Medical Ltd. is an investment holding company. The firm has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The firm's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The firm sells its products in domestic and foreign markets.
See Also
What is Sisram Medical Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
70.2m
USD
Based on the financial report for Jun 30, 2024, Sisram Medical Ltd's Cash & Cash Equivalents amounts to 70.2m USD.
What is Sisram Medical Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-7%
Over the last year, the Cash & Cash Equivalents growth was 12%. The average annual Cash & Cash Equivalents growth rates for Sisram Medical Ltd have been -18% over the past three years , -7% over the past five years .
You don't have any saved screeners yet
